Clinical depression natural history, complications and prognosis: Difference between revisions
No edit summary |
m Bot: Removing from Primary care |
||
| (4 intermediate revisions by 3 users not shown) | |||
| Line 2: | Line 2: | ||
{{Clinical depression}} | {{Clinical depression}} | ||
{{CMG}} | {{CMG}} | ||
==Complications== | ==Complications== | ||
*People who are depressed are more likely to use alcohol or illegal substances. | *People who are depressed are more likely to use alcohol or illegal substances. | ||
* | *Other complications of depression include: | ||
:*Increased risk of physical health problems | :*Increased risk of physical health problems | ||
:*[[Suicide (patient information)|Suicide]] | :*[[Suicide (patient information)|Suicide]] | ||
| Line 21: | Line 16: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Disease]] | |||
[[Category:Psychiatry]] | |||
Latest revision as of 20:59, 29 July 2020
|
Clinical Depression Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Follow-up |
|
Case Studies |
|
Clinical depression natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Clinical depression natural history, complications and prognosis |
|
FDA on Clinical depression natural history, complications and prognosis |
|
CDC on Clinical depression natural history, complications and prognosis |
|
Clinical depression natural history, complications and prognosis in the news |
|
Blogs on Clinical depression natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Complications
- People who are depressed are more likely to use alcohol or illegal substances.
- Other complications of depression include:
- Increased risk of physical health problems
- Suicide
Prognosis
Recurrence is more likely if treatment has not resulted in full remission of symptoms.4 In fact, current guidelines for antidepressant use recommend 4 to 6 months of continuing treatment after symptom resolution to prevent relapse.
Combined evidence from many randomized controlled trials indicates that continuing antidepressant medications after recovery substantially reduces (halves) the chances of relapse. This preventive effect probably lasts for at least the first 36 months of use.[1]
Anecdotal evidence suggests that chronic disease is accompanied by recurrence after prolonged treatment with antidepressants (tachyphylaxis). Psychiatric texts suggest that physicians respond to recurrence by increasing dosage, complementing the medication with a different class, or changing the medication class entirely. The reason for recurrence in these cases is as poorly understood as the change in brain physiology induced by the medications themselves. Possible reasons may include aging of the brain or worsening of the condition. Most SSRI psychiatric medications were developed for short-term use (a year or less) but are widely prescribed for indefinite periods.[2]
References
- ↑ Geddes, JR (22 February 2003). "Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review". Lancet. 361 (9358): 653?61. PMID 12606176. Unknown parameter
|coauthors=ignored (help); Check date values in:|date=(help) - ↑ Psychology Today: Skirmish or Siege?